Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals

Neurobiology of Aging

Volumn 30, Issue 6, 2009, Pages 898-902

  Koschack, Janka ^a   Lütjohann, Dieter ^b   Schmidt Samoa, Carsten ^a   Irle, Eva ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

24S hydroxycholesterol; Aging; Cholesterol; Hippocampus

Indexed keywords

CHOLESTEROL DERIVATIVE; OXYSTEROL;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN METABOLISM; BRAIN SIZE; CHOLESTEROL METABOLISM; COGNITION; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE REGRESSION; PRIORITY JOURNAL;

FEMALE; HIPPOCAMPUS; HUMANS; HYDROXYCHOLESTEROLS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; STATISTICS AS TOPIC;

EID: 65349164191     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.10.010     Document Type: Article

References (24)

1. Björkhem I., Lütjohann D., Breuer O., Sakinis A., and Wennmalm A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J. Biol Chem. 272 (1997) 30178-30184
2. Björkhem I., Lütjohann D., Diczfalusy U., Stahle L., Ahlborg G., and Wahren J. Cholesterol homeostasis in human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39 (1998) 1594-1600
3. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82 (1991) 239-259
4. Den Heijer T., Hofman A., and Koudstaal P.J. Breteler MMB. Serum lipids and hippocampal volume: the link to Alzheimer's disease?. Ann Neurol. 57 (2005) 779-780
5. Den Heijer T., Geerlings M.I., Hoebeek F.E., Hofman A., Koudstaal P.J., and Breteler M.M.B. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch. Gen. Psychiatr. 63 (2006) 57-62
6. Gosche K.M., Mortimer J.A., Smith C.D., Markesbery W.R., and Snowdon D.A. Hippocampal volume as an index of Alzheimer neuropathology. Neurology 58 (2002) 1476-1482
7. Kivipelto M., Helkala E.-L., Laakso M.P., Hänninen T., Hallikainen M., Alhainen K., Soininen H., Tuimilehto J., and Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322 (2001) 1447-1451
8. Koschack J., and Irle E. Small hippocampal size in cognitively normal subjects with coronary artery disease. Neurobiol Aging 26 (2005) 865-871
9. Leoni V., Masterman T., Mousavi F.S., Wretlind B., Wahlund L.O., Diczfalusy U., Hillert J., and Björkhem I. Diagnostic use of cerebral and extracerebral osysterols. Clin Chem Lab Med. 42 (2004) 186-191
10. Lund E.G., Guileyardo J.M., and Russell D.W. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. PNAS 96 (1999) 7238-7243
11. Lütjohann D., Breuer O., Ahlborg G., Nennesmo I., Siden A., Diczfalusy U., and Björkhem I. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. PNAS 93 (1996) 9799-9804
12. Lütjohann D., Papassotiropoulos A., Björkhem I., Locatelli S., Bagli M., Oehring R.D., Schlegel U., Jessen F., Rao M.L., von Bergmann K., and Heun R. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 41 (2000) 195-198
13. Lütjohann D., and von Bergmann K. 24S-hydroxycholesterol: a marker of brain cholesterol metabolism. Pharmacopsychiatry 36 Suppl 2 (2003) S102-S106
14. Michikawa M. Cholesterol paradox: Is high total or low HDL cholesterol level a risk for Alzheimer's disease. J. Neurosci. Res. 72 (2003) 141-146
15. Notkola I.L., Sulkava R., Pekkanan J., Erkinjuntti T., Ehnholm C., Kivinen P., Tuomilehto J., and Nissinen A. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17 (1998) 14-20
16. Papassotiropoulos A., Lütjohann D., Bagli M., Locatelli S., Jessen F., Buschfort R., Ptok U., Björkhem I., von Bergmann K., and Heun R. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J. Psychiatr. Res. 36 (2002) 27-32
17. Pruessner J.C., Li L.M., Serles W., Pruessner M., Collins D.L., Kabani N., Lupien S., and Evans A.C. Volumetry of hippocampus and amygdala with high-resolution MRI and three-dimensional analysis software: minimizing the discrepancies between laboratories. Cereb Cortex 10 (2000) 433-442
18. Teunissen C.E., De Vente J., von Bergmann K., Bosma H., van Boxtel M.P.J., De Bruijn C., Jolles J., Steinbusch H.W.M., and Lütjohann D. Serum cholesterol, precursors and metabolites and cognitive performances in an aging population. Neurobiol. Aging 24 (2003) 147-155
19. Thelen K.M., Falkai P., Bayer T.A., and Lütjohann D. Cholesterol synthesis rate in human hippocampus declines with aging. Neurosci. Lett. 403 (2006) 15-19
20. Wittchen H.U., Zaudig M., and Frydrich T. Strukturiertes Klinisches Interview für DSM-IV. Achse I und II. Göttingen. FRG: Hogrefe (1997)
21. Wolf H., Jekic V., Gertz H.J., Nordberg A., Julin P., and Wahlund L.-O. A critical discussion of the role of neuroimaging in mild cognitive impairment. Acta Neurol. Scand. 107 Suppl. 179 (2003) 52-76
22. Wolf H., Hensel A., Arendt T., Kivipelto M., Winblad B., and Gertz H.J. Serum lipids and hippocampal volume: the link to Alzheimer's disease?. Ann Neurol. 56 (2004) 745-748
23. Wolf H., Kivipelto M., Hensel A., Winblad B., Riedel-Heller S.G., and Gertz H.J. Serum lipids and hippocampal volume: the link to Alzheimer's disease? Author reply. Ann Neurol. 57 (2005) 780
24. Wood W.G., Schroeder F., AvdulovNA, Chochina S.V., and Igbavboa U. Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease. Lipids 34 (1999) 225-234